Commentary: Lest we biopsy: Positron emission tomography-computed tomography as a tool to achieve a "greater good" in the diagnosis and management of the resectable anterior mediastinal mass

J Thorac Cardiovasc Surg. 2023 Jan;165(1):382-383. doi: 10.1016/j.jtcvs.2022.02.057. Epub 2022 Apr 6.

Authors

Andrew E Giles¹, Stephen D Cassivi²

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn. Electronic address: aegiles@gmail.com.
² Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minn.

PMID: 35525804
DOI: 10.1016/j.jtcvs.2022.02.057

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biopsy
Fluorodeoxyglucose F18
Humans
Lung Neoplasms* / pathology
Neoplasm Staging
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography / methods
Radiopharmaceuticals

Substances

Fluorodeoxyglucose F18
Radiopharmaceuticals